Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Vir’s clinical-stage portfolio includes infectious disease programs for chronic hepatitis delta and chronic hepatitis B infections, in addition to multiple oncology programs. Vir also has a preclinical portfolio of programs across a range of other infectious diseases and oncologic malignancies.
We believe the success of our colleagues drives the success of our mission. We are committed to creating a company passionate about equality, inclusion, and respect. When everyone feels supported and encouraged to give their best, we will collectively deliver outstanding results.
THE OPPORTUNITY
Based in San Francisco and reporting to the Senior Vice President of Corporate Communications, you will be responsible for supporting the development and execution of the corporate communications strategy . You have a strong understanding of the drug discovery and development process in the life sciences sector and a passion for story-telling to communicate company strategy and impact. You will bring established relationships with relevant media outlets; internal communications experience; and the ability to influence others and drive alignment across diverse cross-functional teams. You have experience partnering with and advising senior leaders, and be comfortable driving executive visibility activities. Importantly, you possess a self-starting, entrepreneurial spirit and exhibit strong problem-solving skills.
This role is located in our San Francisco headquarters with an expectation of 4 days per week in office.
WHAT YOU'LL DO
- Partner with the SVP of Corporate Communications to define corporate communication strategies that support business objectives and convey the unique value of Vir and its platforms and programs.
- Develop PR materials, including press releases, Q&As, website content, executive talking points, fact sheets, etc., in collaboration with colleagues in Investor Relations, Legal, Alliance Management, Business Development and other parts of the organization.
- Build and enhance relationships with external media outlets including news, business, and industry trade publications, with both traditional and digital media; garner local, regional and national coverage of Vir to meet objectives.
- Partner with Human Resources, Employee Resource Groups and other important internal stakeholders to drive alignment in communication across the organization.
- Work in partnership with R&D Communications to develop multi-channel strategies to share stories of Vir's impact and potential to help people living with a range of infectious diseases and cancers.
- Help drive Vir's website and social media channel strategies and content.
- Identify external opportunities, including media interviews, speaking engagements at industry conferences, and other forums to showcase Vir thought leadership
- Actively manage and direct external agency partners and drive the best value from these relationships.
WHO YOU ARE AND WHAT YOU BRING
- Bachelors' degree with a minimum of 12 years of professional experience in Communications in the pharmaceutical/biotech area is required.
- Demonstrated experience crafting and executing successful traditional media, social media, and internal communications strategies.
- Strong written skills in corporate and scientific content.
- Experience supporting senior leaders with executive communications and thought leadership strategies.
- Demonstrated ability to collaborate, facilitate, and organize across multiple groups and levels of an organization, including direct collaboration with C-suite colleagues.
- Understanding of SEC and FDA regulations affecting communications.
- Must be located in the San Francisco area.
#LI-AM1
#LI-Onsite
WHO WE ARE AND WHAT WE OFFER
The expected salary range for this position is $217,500.00 to $318,000.00. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors.
Vir's compensation and benefits are aligned with the current market and commensurate with the person's experience and qualifications. All full-time employees receive a package that includes: compensation, bonus and equity as well as many other Vir benefits and perks such as: health, dental, vision, life and disability insurance benefits, non-accrual paid time off, company shut down for holidays, commuter benefits, child care reimbursement, education reimbursement, 401K match and lunch each day in the office.
Applicants must currently be authorized to work for any employer in the U.S. We are unable to sponsor or take over sponsorship of an employment Visa at this time.
Vir Biotechnology (“Vir”) is an equal opportunity employer. All employment decisions at Vir are based on legitimate, non-discriminatory business requirements, job duties and individual qualifications. Employment decisions are made without regard to race, color, religion, sex (including pregnancy), gender, gender identity, gender expression, sexual orientation, age, parental status, marital status, national origin, ancestry, disability, medical condition, genetic information (including family medical history), political affiliation, military service or any other legally protected characteristic.
This commitment extends to all management practices and decisions, including recruitment and hiring, compensation, appraisal systems, promotions, training and career development programs. Vir also strongly commits to providing employees with a work environment free of unlawful discrimination or harassment.
Vir Human Resources leads recruitment and employment for Vir. Unsolicited resumes sent to Vir from recruiters do not constitute any type of relationship between the recruiter and Vir and do not obligate Vir to pay fees should we hire from those resumes. We ask that external recruiters and/or agencies not contact or present candidates directly to our hiring manager or employees.
For hires based in the United States, Vir Biotechnology, Inc., participates in E-Verify.
Candidate Privacy Notice
What We Do
Vir Biotechnology, Inc. (in Europe, Humabs BioMed, https://bit.ly/46lQGN2) is an immunology company focused on powering the immune system to address unmet patient needs in infectious disease and beyond. Our powerful R&D engine combines our proprietary monoclonal antibody (mAb) platform with machine learning and artificial intelligence-enhanced capabilities, enabling us to engineer our rich database of human antibodies and deliver transformative medicines for diseases with significant global burden.
Our current pipeline consists of multiple clinical candidates targeting hepatitis B and hepatitis delta viruses and human immunodeficiency virus, including a potential functional cure for chronic hepatitis B and treatment for chronic hepatitis delta. Our portfolio of broad, potent investigational monoclonal antibodies also targets influenza A and B viruses, COVID-19, respiratory syncytial virus/human metapneumovirus and human papillomavirus, and our investigational T cell vaccine aims to prevent HIV. Explore our full pipeline: https://bit.ly/3tr7FPm
We collaborate with some of the world’s leaders in industry as well as government agencies and non-profit organizations enabling us to rapidly advance cutting-edge scientific discoveries and innovative technologies with the potential to benefit people around the world.
We are proud to have been ranked the fastest-growing company in North America on the 2022 Deloitte Technology Fast 500™.
Join us as we pursue our mission to transform lives.
It has come to our attention that there have been various recruitment scams targeting job seekers on LinkedIn. Vir Biotechnology, Inc. is committed to your privacy and will never request sensitive personal information including banking details through email, text message, social media or video software platforms. We also will never request a financial commitment from a candidate as part of the application process. Learn more about Vir’s recruiting process: https://bit.ly/461EgJN